Buruli ulcer

Global Buruli Ulcer Initiative events

WHO Meeting on Buruli ulcer
23–25 March 2015 | Executive Board Room, WHO Headquarters, Geneva, Switzerland

WHO regularly organizes a general meeting in Geneva that brings together representatives from the ministries of health of the affected countries, nongovernmental organizations and research institutions involved in Buruli ulcer (BU) activities to encourage the exchange of new scientific and public health information on the disease, and to coordinate efforts among all partners. The last meeting was held from 25 to 27 March 2013 at the WHO Headquarters in Geneva, Switzerland.

The objectives of this meeting are:

  • To review the epidemiological situation in endemic countries (2013–2014);
  • To share information on activities carried out on Buruli ulcer control and research and achievements made; and
  • To agree on control and research priorities for the next 2 years and coordinate their implementation.

More than 150 people from 23 countries attending the meeting.

WHO FIND consultative meeting on diagnostics for buruli ulcer
Geneva 21 November 2013

Infection with Mycobacterium ulcerans has been documented in more than 33 countries worldwide. The majority of cases are in Sub-Saharan Africa, although the disease also occurs in other regions such as South-East Asia, South America and Western Pacific.

The causative organism of BU is Mycobacterium ulcerans but the modes of transmission have not been identified.

Differents diagnostic tests are currently available for BU.

Buruli in the news!

19 November 2015 | Geneva
New research shows the diagnostic potential of fluorescent thin layer chromatography to detect mycolactone in Buruli ulcer

12 November 2015 | Geneva
Despite limitations, clinical practice and observational data are allowing acquisition of knowledge - crucial to informing international guidance for Buruli ulcer disease management

30 September 2015 | Geneva
Rapid diagnosis of Buruli ulcer now possible at district-level health facilities

05 March 2015 | Geneva
Management of Buruli ulcer–HIV coinfection – Technical update
Ref: WHO/HTM/NTD/IDM/2015.01

10 facts on Buruli ulcer
Read the 10 facts

Laboratory confirmation
Guidance on sampling techniques for laboratory-confirmation of Mycobacterium ulcerans infection (Buruli ulcer disease)